Beijing Scitop Bio Tech Co Ltd Cash Flow Conversion Efficiency
Beijing Scitop Bio Tech Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Beijing Scitop Bio Tech Co Ltd (300858) has a cash flow conversion efficiency ratio of 0.024x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥44.72 Million ≈ $6.54 Million USD) by net assets (CN¥1.83 Billion ≈ $267.24 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Beijing Scitop Bio Tech Co Ltd (2015–2025)
Cash flow conversion efficiency of Beijing Scitop Bio Tech Co Ltd from 2015 to 2025. This chart illustrates how Beijing Scitop Bio Tech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 300858 share price today for real-time trading data and today's change.
Beijing Scitop Bio Tech Co Ltd Cash Flow Conversion Ratio Explained
Beijing Scitop Bio Tech Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Beijing Scitop Bio Tech Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Beijing Scitop Bio Tech Co Ltd ranked by their cash flow conversion efficiency. Also see Beijing Scitop Bio Tech Co Ltd (300858) total market value for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Fujian Raynen Tech Co Ltd
SHG:603933
|
0.037x |
|
Shenzhen Jasic Tech Co
SHE:300193
|
0.030x |
|
Shenzhen Prince New Materials Co Ltd
SHE:002735
|
0.021x |
|
Henan Newland Pharmaceutical Co. Ltd. A
SHE:301277
|
N/A |
|
Aris Water Solutions Inc
NYSE:ARIS
|
0.093x |
|
Guangdong Xiongsu Technology Group Co Ltd
SHE:300599
|
0.001x |
|
Zhejiang Zoenn Design Co Ltd
SHE:300901
|
0.050x |
|
Bahnhof AB Series B
ST:BAHN-B
|
0.072x |
Annual Cash Flow Conversion Efficiency for Beijing Scitop Bio Tech Co Ltd (2015–2025)
The table below shows the annual cash flow conversion efficiency of Beijing Scitop Bio Tech Co Ltd from 2015 to 2025. Review Beijing Scitop Bio Tech Co Ltd free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥1.84 Billion ≈ $269.66 Million |
CN¥123.44 Million ≈ $18.06 Million |
0.067x | -15.65% |
| 2024-12-31 | CN¥1.79 Billion ≈ $261.87 Million |
CN¥142.11 Million ≈ $20.80 Million |
0.079x | +28.30% |
| 2023-12-31 | CN¥1.73 Billion ≈ $253.59 Million |
CN¥107.27 Million ≈ $15.70 Million |
0.062x | -29.26% |
| 2022-12-31 | CN¥1.70 Billion ≈ $248.26 Million |
CN¥148.46 Million ≈ $21.72 Million |
0.088x | -23.23% |
| 2021-12-31 | CN¥967.40 Million ≈ $141.56 Million |
CN¥110.27 Million ≈ $16.14 Million |
0.114x | +59.44% |
| 2020-12-31 | CN¥932.59 Million ≈ $136.47 Million |
CN¥66.67 Million ≈ $9.76 Million |
0.071x | -70.91% |
| 2019-12-31 | CN¥399.83 Million ≈ $58.51 Million |
CN¥98.27 Million ≈ $14.38 Million |
0.246x | -17.16% |
| 2018-12-31 | CN¥301.83 Million ≈ $44.17 Million |
CN¥89.55 Million ≈ $13.10 Million |
0.297x | -0.72% |
| 2017-12-31 | CN¥281.09 Million ≈ $41.13 Million |
CN¥84.00 Million ≈ $12.29 Million |
0.299x | +77.64% |
| 2016-12-31 | CN¥194.57 Million ≈ $28.47 Million |
CN¥32.73 Million ≈ $4.79 Million |
0.168x | +229.95% |
| 2015-12-31 | CN¥52.67 Million ≈ $7.71 Million |
CN¥2.69 Million ≈ $392.95K |
0.051x | -- |
About Beijing Scitop Bio Tech Co Ltd
Beijing Scitop Bio-tech Co., Ltd. engages in the research, development, production, and sale of probiotic, postbiotics, and microecological preparations for animals and plants in China. It provides probiotic and postbiotics for gastrointestinal health, immune regulation, oral health, sleep aid and stress relief, women's health, slimming and fat reduction, kidney and liver protection, blood sugar … Read more